Go Pro

KindlyMD (NAKA) Competitors

KindlyMD logo
$4.93 -0.12 (-2.38%)
As of 04:00 PM Eastern

NAKA vs. FWDI, MAAS, CEPO, TROO, and TONX

Should you buy KindlyMD stock or one of its competitors? KindlyMD's main competitors and comparable companies include Forward Industries (FWDI), Maase (MAAS), Cantor Equity Partners (CEPO), TROOPS (TROO), and Verb Technology (TONX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "multi-sector holdings" industry.

How does KindlyMD compare to Forward Industries?

KindlyMD (NASDAQ:NAKA) and Forward Industries (NASDAQ:FWDI) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.

Forward Industries has a net margin of -2,073.82% compared to KindlyMD's net margin of -7,397.12%. Forward Industries' return on equity of -15.75% beat KindlyMD's return on equity.

Company Net Margins Return on Equity Return on Assets
KindlyMD-7,397.12% -81.32% -54.17%
Forward Industries -2,073.82%-15.75%-15.35%

KindlyMD has a beta of 15.95, meaning that its stock price is 1,495% more volatile than the broader market. Comparatively, Forward Industries has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market.

KindlyMD presently has a consensus price target of $22.33, indicating a potential upside of 353.01%. Forward Industries has a consensus price target of $7.50, indicating a potential upside of 76.06%. Given KindlyMD's stronger consensus rating and higher possible upside, research analysts plainly believe KindlyMD is more favorable than Forward Industries.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KindlyMD
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Forward Industries
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

KindlyMD has higher earnings, but lower revenue than Forward Industries. Forward Industries is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KindlyMD$1.82M47.13-$52.23M-$43.20N/A
Forward Industries$18.19M17.49-$166.97M-$2.05N/A

In the previous week, Forward Industries had 12 more articles in the media than KindlyMD. MarketBeat recorded 17 mentions for Forward Industries and 5 mentions for KindlyMD. KindlyMD's average media sentiment score of 0.48 beat Forward Industries' score of -0.02 indicating that KindlyMD is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
KindlyMD
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Forward Industries
1 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

KindlyMD beats Forward Industries on 8 of the 14 factors compared between the two stocks.

How does KindlyMD compare to Maase?

KindlyMD (NASDAQ:NAKA) and Maase (NASDAQ:MAAS) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, earnings, analyst recommendations and dividends.

Maase has a net margin of 0.00% compared to KindlyMD's net margin of -7,397.12%. Maase's return on equity of 0.00% beat KindlyMD's return on equity.

Company Net Margins Return on Equity Return on Assets
KindlyMD-7,397.12% -81.32% -54.17%
Maase N/A N/A N/A

KindlyMD has a beta of 15.95, indicating that its share price is 1,495% more volatile than the broader market. Comparatively, Maase has a beta of 0.03, indicating that its share price is 97% less volatile than the broader market.

Maase has higher revenue and earnings than KindlyMD.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KindlyMD$1.82M47.13-$52.23M-$43.20N/A
Maase$784.35M0.34-$27.36MN/AN/A

KindlyMD currently has a consensus price target of $22.33, indicating a potential upside of 353.01%. Given KindlyMD's stronger consensus rating and higher probable upside, equities analysts plainly believe KindlyMD is more favorable than Maase.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KindlyMD
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Maase
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, KindlyMD had 4 more articles in the media than Maase. MarketBeat recorded 5 mentions for KindlyMD and 1 mentions for Maase. Maase's average media sentiment score of 1.87 beat KindlyMD's score of 0.48 indicating that Maase is being referred to more favorably in the news media.

Company Overall Sentiment
KindlyMD Neutral
Maase Very Positive

Summary

KindlyMD and Maase tied by winning 6 of the 12 factors compared between the two stocks.

How does KindlyMD compare to Cantor Equity Partners?

Cantor Equity Partners (NASDAQ:CEPO) and KindlyMD (NASDAQ:NAKA) are both small-cap finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, media sentiment, risk, profitability, analyst recommendations and valuation.

KindlyMD has a consensus price target of $22.33, indicating a potential upside of 353.01%. Given KindlyMD's stronger consensus rating and higher possible upside, analysts clearly believe KindlyMD is more favorable than Cantor Equity Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cantor Equity Partners
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
KindlyMD
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Cantor Equity Partners has a beta of -0.05, indicating that its stock price is 105% less volatile than the broader market. Comparatively, KindlyMD has a beta of 15.95, indicating that its stock price is 1,495% more volatile than the broader market.

In the previous week, KindlyMD had 2 more articles in the media than Cantor Equity Partners. MarketBeat recorded 5 mentions for KindlyMD and 3 mentions for Cantor Equity Partners. Cantor Equity Partners' average media sentiment score of 0.98 beat KindlyMD's score of 0.48 indicating that Cantor Equity Partners is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cantor Equity Partners
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
KindlyMD
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Cantor Equity Partners has higher earnings, but lower revenue than KindlyMD. Cantor Equity Partners is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cantor Equity PartnersN/AN/A-$6.66M-$0.47N/A
KindlyMD$1.82M47.13-$52.23M-$43.20N/A

Cantor Equity Partners has a net margin of 0.00% compared to KindlyMD's net margin of -7,397.12%. Cantor Equity Partners' return on equity of 0.00% beat KindlyMD's return on equity.

Company Net Margins Return on Equity Return on Assets
Cantor Equity PartnersN/A N/A -2.95%
KindlyMD -7,397.12%-81.32%-54.17%

Summary

KindlyMD beats Cantor Equity Partners on 7 of the 13 factors compared between the two stocks.

How does KindlyMD compare to TROOPS?

TROOPS (NASDAQ:TROO) and KindlyMD (NASDAQ:NAKA) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, valuation and profitability.

TROOPS has higher revenue and earnings than KindlyMD.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TROOPS$17.10M14.22-$27.91MN/AN/A
KindlyMD$1.82M47.13-$52.23M-$43.20N/A

In the previous week, TROOPS had 1 more articles in the media than KindlyMD. MarketBeat recorded 6 mentions for TROOPS and 5 mentions for KindlyMD. KindlyMD's average media sentiment score of 0.48 beat TROOPS's score of -0.26 indicating that KindlyMD is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TROOPS
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
2 Very Negative mention(s)
Neutral
KindlyMD
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

KindlyMD has a consensus price target of $22.33, indicating a potential upside of 353.01%. Given KindlyMD's stronger consensus rating and higher probable upside, analysts plainly believe KindlyMD is more favorable than TROOPS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TROOPS
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
KindlyMD
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

TROOPS has a beta of 3.49, meaning that its share price is 249% more volatile than the broader market. Comparatively, KindlyMD has a beta of 15.95, meaning that its share price is 1,495% more volatile than the broader market.

TROOPS has a net margin of 0.00% compared to KindlyMD's net margin of -7,397.12%. TROOPS's return on equity of 0.00% beat KindlyMD's return on equity.

Company Net Margins Return on Equity Return on Assets
TROOPSN/A N/A N/A
KindlyMD -7,397.12%-81.32%-54.17%

Summary

TROOPS and KindlyMD tied by winning 6 of the 12 factors compared between the two stocks.

How does KindlyMD compare to Verb Technology?

Verb Technology (NASDAQ:TONX) and KindlyMD (NASDAQ:NAKA) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, valuation and profitability.

KindlyMD has a consensus price target of $22.33, indicating a potential upside of 353.01%. Given KindlyMD's stronger consensus rating and higher probable upside, analysts plainly believe KindlyMD is more favorable than Verb Technology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Verb Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
KindlyMD
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

In the previous week, Verb Technology and Verb Technology both had 5 articles in the media. KindlyMD's average media sentiment score of 0.48 beat Verb Technology's score of 0.20 indicating that KindlyMD is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Verb Technology
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
KindlyMD
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Verb Technology has a beta of 0.68, meaning that its share price is 32% less volatile than the broader market. Comparatively, KindlyMD has a beta of 15.95, meaning that its share price is 1,495% more volatile than the broader market.

Verb Technology has a net margin of -532.78% compared to KindlyMD's net margin of -7,397.12%. Verb Technology's return on equity of -58.69% beat KindlyMD's return on equity.

Company Net Margins Return on Equity Return on Assets
Verb Technology-532.78% -58.69% -57.33%
KindlyMD -7,397.12%-81.32%-54.17%

7.2% of Verb Technology shares are held by institutional investors. 21.4% of Verb Technology shares are held by insiders. Comparatively, 24.5% of KindlyMD shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

KindlyMD has lower revenue, but higher earnings than Verb Technology. Verb Technology is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Verb Technology$12.78M11.59-$148.48M-$2.84N/A
KindlyMD$1.82M47.13-$52.23M-$43.20N/A

Summary

KindlyMD beats Verb Technology on 10 of the 15 factors compared between the two stocks.

Get KindlyMD News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAKA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NAKA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NAKA vs. The Competition

MetricKindlyMDFinancial Services IndustryFinance SectorNASDAQ Exchange
Market Cap$85.78M$26.81B$14.09B$13.05B
Dividend YieldN/A5.92%5.88%10.72%
P/E Ratio-0.1118.6829.3325.30
Price / Sales47.13402.95510.18101.40
Price / CashN/A172.0039.9750.75
Price / Book0.103.093.706.33
Net Income-$52.23M$1.09B$1.31B$347.70M
7 Day Performance-1.00%0.64%0.74%1.07%
1 Month Performance23.87%-0.54%1.77%1.03%
1 Year Performance-99.18%-11.07%12.26%20.77%

KindlyMD Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NAKA
KindlyMD
3.3921 of 5 stars
$4.93
-2.4%
$22.33
+353.0%
-99.0%$85.78M$1.82MN/AN/A
FWDI
Forward Industries
2.2828 of 5 stars
$4.24
+0.4%
$7.45
+75.9%
N/A$316.27M$18.19MN/A100
MAAS
Maase
1.0825 of 5 stars
$18.62
-4.6%
N/A+309.9%$296.36M$784.35MN/A550
CEPO
Cantor Equity Partners
0.5466 of 5 stars
$10.67
+0.1%
N/A-1.4%$271.96MN/AN/A2
TROO
TROOPS
0.1984 of 5 stars
$1.99
+3.0%
N/A+124.4%$242.73M$17.10MN/A20

Related Companies and Tools


This page (NASDAQ:NAKA) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners